BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34262144)

  • 21. p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT- and ERK-dependent activation of NF-κB pathway.
    Tyagi N; Bhardwaj A; Singh AP; McClellan S; Carter JE; Singh S
    Oncotarget; 2014 Sep; 5(18):8778-89. PubMed ID: 25238288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The p21-activated kinase 4-Slug transcription factor axis promotes epithelial-mesenchymal transition and worsens prognosis in prostate cancer.
    Park JJ; Park MH; Oh EH; Soung NK; Lee SJ; Jung JK; Lee OJ; Yun SJ; Kim WJ; Shin EY; Kim EG
    Oncogene; 2018 Sep; 37(38):5147-5159. PubMed ID: 29849120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-199a/b-3p inhibits colorectal cancer cell proliferation, migration and invasion through targeting PAK4 and BCAR3.
    Hou J; Mi X; Liu N; Li X; Li XN; Yang Y; Lu X; Fang Y; Jin NY
    Eur J Med Res; 2022 Jul; 27(1):121. PubMed ID: 35842733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer.
    Zhao CC; Zhan MN; Liu WT; Jiao Y; Zhang YY; Lei Y; Zhang TT; Zhang CJ; Du YY; Gu KS; Wei W
    Cancer Lett; 2020 Nov; 493():120-127. PubMed ID: 32829006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
    Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
    Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the β-catenin pathway in colorectal cancer.
    Kang JH; Jang JE; Mishra SK; Lee HJ; Nho CW; Shin D; Jin M; Kim MK; Choi C; Oh SH
    J Ethnopharmacol; 2015 Sep; 173():303-12. PubMed ID: 26210065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncogenic PAK4 regulates Smad2/3 axis involving gastric tumorigenesis.
    Wang C; Li Y; Zhang H; Liu F; Cheng Z; Wang D; Wang G; Xu H; Zhao Y; Cao L; Li F
    Oncogene; 2014 Jun; 33(26):3473-84. PubMed ID: 23934187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-346-5p promotes colorectal cancer cell proliferation in vitro and in vivo by targeting FBXL2 and activating the β-catenin signaling pathway.
    Pan S; Wu W; Ren F; Li L; Li Y; Li W; Wang A; Liu D; Dong Y
    Life Sci; 2020 Mar; 244():117300. PubMed ID: 31953162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PAK4 Methylation by SETD6 Promotes the Activation of the Wnt/β-Catenin Pathway.
    Vershinin Z; Feldman M; Chen A; Levy D
    J Biol Chem; 2016 Mar; 291(13):6786-95. PubMed ID: 26841865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p21-Activated kinase 4 promotes prostate cancer progression through CREB.
    Park MH; Lee HS; Lee CS; You ST; Kim DJ; Park BH; Kang MJ; Heo WD; Shin EY; Schwartz MA; Kim EG
    Oncogene; 2013 May; 32(19):2475-82. PubMed ID: 22710715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer.
    Tang Q; Chen J; Di Z; Yuan W; Zhou Z; Liu Z; Han S; Liu Y; Ying G; Shu X; Di M
    J Exp Clin Cancer Res; 2020 Nov; 39(1):232. PubMed ID: 33153498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
    Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
    Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein Kinase C-ζ stimulates colorectal cancer cell carcinogenesis via PKC-ζ/Rac1/Pak1/β-Catenin signaling cascade.
    Islam SMA; Patel R; Acevedo-Duncan M
    Biochim Biophys Acta Mol Cell Res; 2018 Apr; 1865(4):650-664. PubMed ID: 29408512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships among
    Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
    World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TMEM97 is transcriptionally activated by YY1 and promotes colorectal cancer progression via the GSK-3β/β-catenin signaling pathway.
    Mao D; Zhang X; Wang Z; Xu G; Zhang Y
    Hum Cell; 2022 Sep; 35(5):1535-1546. PubMed ID: 35907137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling.
    Kaur M; Velmurugan B; Tyagi A; Agarwal C; Singh RP; Agarwal R
    Neoplasia; 2010 May; 12(5):415-24. PubMed ID: 20454513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1/β-catenin degradation and is targeted for GSK3B/GSK3β-mediated phosphorylation and degradation.
    Wu H; Lu XX; Wang JR; Yang TY; Li XM; He XS; Li Y; Ye WL; Wu Y; Gan WJ; Guo PD; Li JM
    Autophagy; 2019 Sep; 15(9):1506-1522. PubMed ID: 30806153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of neuroblastoma proliferation by PF-3758309, a small-molecule inhibitor that targets p21-activated kinase 4.
    Li Z; Li X; Xu L; Tao Y; Yang C; Chen X; Fang F; Wu Y; Ding X; Zhao H; Li M; Qian G; Xu Y; Ren J; Du W; Wang J; Lu J; Hu S; Pan J
    Oncol Rep; 2017 Nov; 38(5):2705-2716. PubMed ID: 29048629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.